Patent · US Active

Method of fabricating an implantable medical device comprising a rapamycin derivative

US9610385B2 · kind B2 · utility

0Cited by

8References

24Claims

0Family size

Assignee

Abbott Cardiovascular Systems, Inc. · US

Inventors

Stephen D. Pacetti · San Jose, US
Julia Fox · Redwood City, US

Key dates

Filing date	Mar 7, 2013
Grant date	Apr 4, 2017
Priority date	—
Expiry date	May 9, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T29/49885
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to an method of manufacture of an implantable medical device comprising an oxygen-sensitive rapamycin derivative that is protected by addition of an antioxidant during the manufacturing process where the amount of antioxidant added at the outset of the processing is such that when the device is fully fabricated, sterilized and packaged the amount of antioxidant has reduced to a minimal, preferably non-detect, amount.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.